Morning Wire - From Diet to Drugs: Inside HHS’s Push for Bold Reforms

Episode Date: September 27, 2025

As the MAHA makeover takes shape across the country, HHS releases a new strategy focused on addressing everything from childhood chronic disease to new dietary guidelines. Get the facts first on Morning Wire. - - - Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 - - - Today's Sponsor: Ethos - Get your free quote at https://Ethos.com/WIRE - - - Privacy Policy: https://www.dailywire.com/privacy morning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Marty McCary has entered the FDA as its new commissioner amid sweeping changes and groundbreaking findings. In this episode, Dr. McCurry explains the science behind the administration's announcement earlier this week about a potential cause for autism. I'm Georgia Howe with Daily Wire executive editor John Bickley, and this is a weekend edition of Morning Wire. Losing someone close to you can change everything, and it's impossible not to think about what the future holds. The last thing any of us want is for our loved ones to struggle with bills and expenses during an already difficult time. That's where life insurance from ethos comes in, giving you peace of mind that your family will be protected no matter what. Ethos makes getting life insurance surprisingly simple and affordable. Their completely online platform eliminates the hassle of traditional

insurance, no medical exams, no lengthy appointments, just a few quick health questions, and you can get a quote in as little as 10 minutes. You might be surprised to learn that quality coverage can cost as little as $2 a day, and with ethos, you can customize your policy to fit your budget while still getting up to $3 million in protection. The customer, the company has earned serious recognition, too. Business insider named Ethos the number one no medical exam, instant life insurance provider as of March 2025, and they boast an impressive 4.8 star rating on Trust Pilot. Protect your family with life insurance from Ethos.

Your free quote at ethos.com slash wire. That's ethOS.com slash wire today. Joining us now to discuss is FDA Commissioner and longtime Morning Wire contributor, Dr. Marty McCarrie. Dr. McCarrie, thanks so much for coming on. Good to be with you, Georgia. So we had a very significant announcement this week regarding autism research. Tell us, first, what was that announcement, and then what's the FDA's role going to be?

So we're taking autism very seriously and identified a potential cause that we're letting the public know about, and a potential treatment that hundreds of thousands of kids with severe autism would likely qualify for. And that is we're letting people know about the potential risks of acetaminopin in pregnancy. there have been large studies linking that medication to autism in children subsequently. And so we are going to start the process to change the label. And I've sent a dear doctor letter to all U.S. physicians, letting them know about the association because we now have good data from large studies. And the Harvard School of Public Health dean has made a very conclusive statement

that he believes the association is causal. So when you have that weight of evidence, you have to take it seriously an error on the side of safety, especially since the vast majority of low-grade fevers do not need to be treated as we reflexively did in medical school and in training. Does it matter when in the pregnancy it was? Is it dose-dependent? Is it like long-term use? What are they seeing in the data? Well, there are associations between the duration of acetamin use and the risk of autism in children. subsequently, as well as the proximity to the time of birth. There's been acetaminophen that's shown up in the cord blood of newborn babies, and that cord blood level has been associated with the

degree of risk. So there's enough evidence here for us to say, hey, we don't need a 10-year randomized control trial. We have an epidemic of autism that has increased 400% in the recent decades, and we don't have a known cause. Now, this may be a cause, but when you have enough evidence to suggest an association, and you have no other plausible cause, we have a duty to notify parents and doctors. Now, you mentioned there's also a new treatment being discussed. Tell us about that new treatment, who it could work for, and what the mechanism is, just in a broad general way. The treatment is called Leukovorin, or Vitamin B6. It's a very good. It's a very much. It's a very or vitamin B6.

It's been around for nearly a century, but only recently have we recognized that some kids with autism actually have an autoimmune disease. The mechanism may be that the body is creating antibodies that block the folate receptors on their brain, restricting the ability of folate to get into the cerebrum. And so what that does is it actually creates a situation where you could have high levels of folate in your diet or in your blood, but it's not getting it. getting in the brain. And some doctors have actually started to test for this folate antibody, and they will then move

on to treat some kids with this philinic acid or vitamin B12 that bypasses the receptor. Now, there's been a lot of controversy about HHS, in particular taking on autism. They'll talk about how vaccines are completely safe, et cetera, et cetera. What do you make of the controversies? And can you separate some of the fact from fiction with regards to what the public believes about how you guys are approaching this? Look, Secretary Kennedy is asking questions that the American people are asking. And so we have this odd new political landscape that's penetrated science where you're supposedly not allowed to ask certain questions. It's created a tremendous amount of distrust.

But I can tell you the purpose of science itself is to investigate questions. We've got blind spots. There are sacred cow topics we're not supposed to talk about. Well, Dr. J. Baratari, Dr. Oz, and myself, we come from very respected institutions, Stanford, Columbia, and Johns Hopkins. We're using the scientific method to try to tackle the big questions that are put in front of us. We're using gold standard science and common sense. And we have a direct charge from President Trump to go bold, do what's right scientifically,

and not worry about the lobbyists and the corporations. Zooming out a little bit, you just took the helm at the FDA. What are your, say, top three goals there? And what could we see change under your leadership? Well, look, Georgia, I want to see more cures for the American people, and I want to see healthier food for children. We've taken huge steps in both of those areas. We have streamlined the approval process at the FDA

so we can get a decision out in weeks, instead of a year. We're going to prioritize drugs that reduce downstream health care utilization, where the drug is made in the United States for a national security issue, and anything that meets a large unmet public health need. We are also seeing tremendous cooperation now from the food industry on our goals, not just to remove the nine petroleum-based food dyes, but the next tier of chemicals. We've seen companies remove titanium dioxide. We've seen just last week, Tyson, one of the largest food manufacturers in the United States, agreed to remove all high fructose corn syrup and titanium dioxide and BHT, a preservative where there are health concerns.

So we're seeing tremendous strides in healthier food for children. We've seen the first ever SNAP program waivers so that states don't have to use taxpayer dollars for junk food and sugary drinks, and we're going to keep going. We've also launched a series of initiatives to eliminate animal testing requirements at the FDA, to use more AI and computational modeling, and to deliver more cures. I'd like to see a cure for type 1 diabetes or a meaningful treatment in the next couple of years, and I think you're going to see it, for neurodegenerative diseases that are otherwise hopeless and disabling, for certain types of cancer, stage 1 and 2 GI cancers, you're going to see a powerful treatment, in my opinion, likely come out soon in those areas. And for PTSD, we still

lose 8,000 veterans a year to suicide. We lose more veterans a year to suicide than we did the entire Afghan and Iraq wars. We owe it to them to get a decision out quickly from the FDA on potentially promising therapies for PTSD, and we're going to do that. Other countries have all these SPF or have all these sun protective chemicals that we're not allowed to have. Other comparable countries have like 54 chemicals they're allowed to use. They have much more elegant formulas, but we have a very limited amount of chemicals that we're allowed to have here. Do you see that opening up anytime soon? Yeah, we are going to open that up, Georgia, because what we see at the FDA when we walked in there, first of all, it was a mess. They were approving drugs where the cells of

Americans were sent to China for gene editing and then sent back to the U.S. for infusion in American patients. We found a lot of broken processes, and it's going to take some time. But one of those is the remnant paternalistic approach to medicine. That is, we can't allow you to try certain sunscreens used in Europe because we have to decide first that they're safe for you. And many of those processes are deep in regulation. they create these cookbooks or recipes at the FDA

and say if you don't follow this exact recipe, then you can't have a product on the U.S. market. And so we're taking that head on. All right. Well, thank you so much for coming on today. Good to be with you, Georgia. That was FDA Commissioner, Dr. Marty McCarrie, and this has been a weekend edition of Morning Wire.